
cis-Octahydroisoindole | CAS:1470-99-1
cis-Octahydroisoindole
- 名称:顺式全氢异吲哚 | cis-Octahydroisoindole
- CAS号:1470-99-1
- 别名:
- 分子式:C8H15N
- 分子量:125.21
- EINESC号:
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Antibiotics attenuate anti-scratching behavioral effect of ginsenoside Re in mice.Se-Eun Jang et al.Journal of ethnopharmacology, 142(1), 105-112 (2012-08-03)
[Pharmacokinetics of ginsenosides Rg1 and its metabolites in rats].Liang Feng et al.Yao xue xue bao = Acta pharmaceutica Sinica, 45(5), 636-640 (2010-10-12)
Protective effect of ginsenosides Rg(2) and Rh(1) on oxidation-induced impairment of erythrocyte membrane properties.Keiichi Samukawa et al.Biorheology, 45(6), 689-700 (2008-12-10)
Biotransformation of ginsenoside Rf to Rh1 by recombinant beta-glucosidase.Chang-Chun Ruan et al.Molecules (Basel, Switzerland), 14(6), 2043-2048 (2009-06-11)
[Determination and enzymolysis preparation of ginsenoside Rh1].Jingang Hou et al.Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 34(23), 3030-3033 (2010-03-13)
Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression.Ji-Sun Jung et al.Journal of neurochemistry, 115(6), 1668-1680 (2010-10-26)
Determination of 20(S)-ginsenoside Rh1 and its aglycone 20(S)-protopanaxatriol in rat plasma by sensitive LC-APCI-MS method and its application to pharmacokinetic study.Li Lai et al.European journal of mass spectrometry (Chichester, England), 15(1), 57-65 (2009-01-29)
A Strategy for Selecting "Q-Markers" of Chinese Medical Preparation via Components Transfer Process Analysis with Application to the Quality Control of Shengmai Injection.Chunxia Zhao et al.Molecules (Basel, Switzerland), 24(9) (2019-05-15)
Degradation of ginsenosides in humans after oral administration.Mona Abdel Tawab et al.Drug metabolism and disposition: the biological fate of chemicals, 31(8), 1065-1071 (2003-07-18)
Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction.Jianguo Sun et al.Journal of pharmaceutical and biomedical analysis, 38(1), 126-132 (2005-05-24)
Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1's metabolites ginsenoside Rh1 and protopanaxatriol.Yu-Zhu Wang et al.Journal of pharmacological sciences, 109(4), 504-510 (2009-04-18)
Microbial transformation of 20(S)-protopanaxatriol-type saponins by Absidia coerulea.Guangtong Chen et al.Journal of natural products, 70(7), 1203-1206 (2007-07-17)
Ginsenoside Rh1 suppresses inducible nitric oxide synthase gene expression in IFN-gamma-stimulated microglia via modulation of JAK/STAT and ERK signaling pathways.Ji-Sun Jung et al.Biochemical and biophysical research communications, 397(2), 323-328 (2010-06-01)
[A quantitative method using one marker for simultaneous assay of ginsenosides in Panax ginseng and P. notoginseng].Jing-jing Zhu et al.Yao xue xue bao = Acta pharmaceutica Sinica, 43(12), 1211-1216 (2009-02-28)
[Studies on chemical constituents from rhizomes of Panax notoginseng].Jiang Zeng et al.Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 30(11), 1388-1391 (2008-03-08)
Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway.Yeo-Jin Choi et al.Fitoterapia, 82(6), 911-919 (2011-05-25)
Effect of ginsenoside Rh1 on myocardial injury and heart function in isoproterenol-induced cardiotoxicity in rats.Yusheng Gai et al.Toxicology mechanisms and methods, 22(8), 584-591 (2012-06-15)
Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes.Yong Liu et al.Planta medica, 72(2), 126-131 (2006-02-24)
Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation.Wan Gu et al.Biological & pharmaceutical bulletin, 36(1), 102-107 (2013-01-11)
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 from protopanaxatriol-type ginseng saponin mixture.Sung-Ryong Ko et al.Planta medica, 69(3), 285-286 (2003-04-05)
A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells.YoungJoo Lee et al.The Journal of steroid biochemistry and molecular biology, 84(4), 463-468 (2003-05-07)
Cloning and heterologous expression of UDP-glycosyltransferase genes from Bacillus subtilis and its application in the glycosylation of ginsenoside Rh1.S L Luo et al.Letters in applied microbiology, 60(1), 72-78 (2014-10-21)
Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells.Ji-Hae Yoon et al.European journal of pharmacology, 679(1-3), 24-33 (2012-02-09)
Characterization of pharmacokinetic profiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro.Li Lai et al.Planta medica, 75(8), 797-802 (2009-03-07)
Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities.Eun-Kyung Park et al.International archives of allergy and immunology, 133(2), 113-120 (2004-01-24)
The effects of ginsenoside Re and its metabolite, ginsenoside Rh1, on 12-O-tetradecanoylphorbol 13-acetate- and oxazolone-induced mouse dermatitis models.Yong-Wook Shin et al.Planta medica, 72(4), 376-378 (2006-03-25)
Biotransformation of ginsenoside Rb1 to Gyp-XVII and minor ginsenoside Rg3 by endophytic bacterium Flavobacterium sp. GE 32 isolated from Panax ginseng.Y Fu Letters in applied microbiology, 68(2), 134-141 (2018-10-27)
Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice.Hua Zheng et al.International immunopharmacology, 11(4), 511-518 (2011-01-18)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!